Related Experiment Video
Updated: Jan 5, 2026
10:36
Rare Event Detection Using Error-corrected DNA and RNA Sequencing
Published on: August 3, 2018
12.5K
MIAmS: microsatellite instability detection on NGS amplicons data.
Frédéric Escudié1, Charles Van Goethem2, David Grand1
1Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, CHU Toulouse, France.
Bioinformatics (Oxford, England)
|October 25, 2019
Summary
MIAmS is a new tool that accurately determines microsatellite instability (MSI) status from next-generation sequencing (NGS) data without needing normal tissue. This application simplifies MSI analysis for cancer diagnostics and research.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- Microsatellite instability (MSI) is a key marker for DNA mismatch repair deficiency in cancer.
- Current MSI testing methods are laborious and time-consuming.
- Next-generation sequencing (NGS) offers a more efficient approach for MSI analysis.
Purpose of the Study:
- To introduce MIAmS, a novel application for determining MSI status from amplicon NGS data.
- To provide a user-friendly and accurate tool for MSI analysis in oncology.
- To develop a method that does not require paired normal tissue.
Main Methods:
- Development of the MIAmS application for processing amplicon NGS data.
- Utilizing MIAmS to tag microsatellite status directly from tumor sample data.
- Validation of MIAmS accuracy and robustness.
Main Results:
- MIAmS accurately determines MSI status from amplicon NGS.
- The application does not require paired normal tissue for analysis.
- MIAmS provides a user-friendly report for result interpretation.
Conclusions:
- MIAmS offers an accurate, scalable, and efficient method for MSI status determination.
- This tool simplifies MSI analysis, aiding in cancer diagnostics and research.
- MIAmS enhances the utility of NGS in molecular oncology.
